Fulcrum Therapeutics, Inc. (FULC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.65 |
| Open | 7.90 |
| Bid | 7.71 x 100 |
| Ask | 7.75 x 200 |
| Day's range | 7.70 - 8.05 |
| 52-week range | 2.65 - 13.70 |
| Volume | |
| Avg. volume | 625,969 |
| Market cap | 481.69M |
| Beta (5Y monthly) | 2.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
CEO, President & Director of Fulcrum Therapeutics Alexander Sapir Buys More Stock
Investors who take an interest in Fulcrum Therapeutics, Inc. ( NASDAQ:FULC ) should definitely note that the CEO...
- Simply Wall St.
Fulcrum Therapeutics Full Year 2023 Earnings: Beats Expectations
Fulcrum Therapeutics ( NASDAQ:FULC ) Full Year 2023 Results Key Financial Results Net loss: US$97.3m (loss narrowed by...
- Insider Monkey
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript February 27, 2024 Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44. FULC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Fulcrum […]
© 2024 Yahoo. All rights reserved.